BioCentury
ARTICLE | Clinical News

Activase alteplase: Phase III data; marketed to treat ischemic stroke, heart attack, and massive pulmonary embolism

January 29, 2001 8:00 AM UTC

In the 150-patient, double-blind Phase III Cardiovascular thrombolytic to Open Occluded Lines (COOL) study, DNA's Activase was shown to dissolve blood clots blocking long-term, in-dwelling catheters. ...